Therapeutic Use of Human Amnion-Derived Products: Cell-Based Therapy for Liver Disease
- 13 July 2016
- journal article
- Published by Springer Science and Business Media LLC in Current Pathobiology Reports
- Vol. 4 (3), 157-167
- https://doi.org/10.1007/s40139-016-0112-8
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Improved Amino Acid, Bioenergetic Metabolite and Neurotransmitter Profiles following Human Amnion Epithelial Cell Transplant in Intermediate Maple Syrup Urine Disease MiceMolecular Genetics and Metabolism, 2013
- Changes in Culture Expanded Human Amniotic Epithelial Cells: Implications for Potential Therapeutic ApplicationsPLOS ONE, 2011
- Hepatic differentiation of amniotic epithelial cellsHepatology, 2011
- A review of immune transfer by the placentaJournal of Reproductive Immunology, 2010
- Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Preservation, sterilization and de-epithelialization of human amniotic membrane for use in ocular surface reconstructionBiomaterials, 2009
- Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cellsClinical and Experimental Immunology, 2008
- Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2Proceedings of the National Academy of Sciences of the United States of America, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- SUCCESSFUL THERAPY OF NIEMANN-PICK DISEASE BY IMPLANTATION OF HUMAN AMNIOTIC MEMBRANETransplantation, 1987